Zobrazeno 1 - 1
of 1
pro vyhledávání: '"J. Frederiek Reijneveld"'
Autor:
Daan Augustijn, Karli R. Reiding, C. Erik Hack, Louis J. Bont, Maaike Nederend, Jeanette H. W. Leusen, Manfred Wuhrer, Frank E. J. Coenjaerts, Shamir R. Jacobino, Jan Meeldijk, J. H. Marco Jansen, J. Frederiek Reijneveld
Publikováno v:
mAbs, 10(3), 453. Landes Bioscience
mAbs
mAbs, 10(3), 453-462
mAbs
mAbs, 10(3), 453-462
Respiratory syncytial virus (RSV) infection is a leading cause of hospitalization and mortality in young children. Protective therapy options are limited. Currently, palivizumab, a monoclonal IgG1 antibody, is the only licensed drug for RSV prophylax
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a3cd91f31232627ce6680f38ab00673
https://doi.org/10.1080/19420862.2018.1433974
https://doi.org/10.1080/19420862.2018.1433974